This was in accordance with previous study where poorly-differentiated gastric adenocarcinomas expressed more CD133 than well-differentiated gastric adenocarcinomas, and CD133 expression increased with the increase in the malignancy grades of gastric cancer [24]. This evidence concerns the gene PROM1 and gastric cancer.